subgroup
of
drug)
→
ReceivesAction
→
approved in canada
Typicality: | 0.287 |
Saliency: | 0.088 |
for the treatment of multiple sclerosis | 2 | purpose |
prescription drug → be approved in → canada | 4 |
negative | neutral | positive |
0.119 | 0.583 | 0.298 |
Raw frequency | 4 |
Normalized frequency | 0.088 |
Modifier score | 0.500 |
Perplexity | 68.870 |